Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Protocol for Sub-Study of the ASCOT Trial
  • Published:

Protocol for Sub-study of the ASCOT Trial

The effects of cardiac events on quality of life and indirect costs

Journal of Human Hypertension volume 15, pages S91–S93 (2001)Cite this article

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

References

  1. Jönsson B et alHealth economics of prevention of coronary heart disease and vascular events: a cost-effectiveness analysis based on the Anglo-Scandinavian Cardiac Outcomes Trial (ASCOT) J Hum Hypertens 2001 15 (Suppl 1) S53–S56

    Article  Google Scholar 

  2. Jönsson B Cost-benefit of treating hypertension Clin Exp Hypertens 1999 21 987–997

    Article  Google Scholar 

  3. Johannesson M The cost effectiveness of hypertension treatment in Sweden PharmacoEconomics 1995 7 242–250

    Article  CAS  Google Scholar 

  4. Johannesson M et alCost effectiveness of simvistatin treatment to lower cholesterol levels inpatients with coronary heart disease N Engl J Med 1997 336 332–336

    Article  CAS  Google Scholar 

  5. The EuroQol Group EuroQol: A new facility for the measurement of health-related quality of life Health Policy 1990 16 199–208

    Article  Google Scholar 

  6. Zethraeus N et alCosts of coronary heart disease and stroke: the case of Sweden J Int Med 1999 246 151–159

    Article  CAS  Google Scholar 

  7. Tidermark J, Ponzer S, Zethraeus N Quality of life as an outcome measure after femoral neck fracture Acta Ortopaedica Scand (submitted)

  8. Lundberg L et alHealth-state utilities in a general population in relation to age, gender, and socioeconomic factors Eur J Pub Health 1999 16 211–217

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Stockholm School of Economics, Box 6501, Stockholm, SE-113 83, Sweden

    B Jönsson

  2. Brunel University, Uxbridge, Middlesex UB8 3PH, UK

    M Buxton

  3. Division of Internal Medicine, Karolinska Institutet, Danderyd Hospital, Danderyd, SE-182 88, Sweden

    T Kahan

  4. Department of Clinical Pharmacology, Cardiovascular Studies Unit, Imperial College School of Medicine, St Mary’s Campus, London, W2 1PG, UK

    NR Poulter

  5. Pfizer AB, P O Box 501, Täby, SE-183 25, Sweden

    P Svarvar

Authors
  1. B Jönsson
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. M Buxton
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. T Kahan
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. NR Poulter
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. P Svarvar
    View author publications

    You can also search for this author in PubMed Google Scholar

Consortia

for the ASCOT Health Economic Working Group

Corresponding author

Correspondence to NR Poulter.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Jönsson, B., Buxton, M., Kahan, T. et al. The effects of cardiac events on quality of life and indirect costs. J Hum Hypertens 15 (Suppl 1), S91–S93 (2001). https://doi.org/10.1038/sj.jhh.1001214

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.jhh.1001214

Keywords

This article is cited by

Search

Advanced search

Quick links